Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival?
作者信息
Groth Shawn S, Burt Bryan M
机构信息
Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S310. doi: 10.21037/atm.2019.10.25.
Abstract
摘要
相似文献
1
Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival?
Ann Transl Med. 2019 Dec;7(Suppl 8):S310. doi: 10.21037/atm.2019.10.25.
2
Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):319-328. doi: 10.1016/j.ijrobp.2019.06.079. Epub 2019 Jun 19.
3
ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.
Pathol Res Pract. 2014 Oct;210(10):656-61. doi: 10.1016/j.prp.2014.06.013. Epub 2014 Jun 27.
4
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cTNM) (NCT03001596).
BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.
5
Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.
J Gastrointest Cancer. 2017 Mar;48(1):42-49. doi: 10.1007/s12029-016-9870-0.
6
Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.
Sci Rep. 2018 Feb 1;8(1):2180. doi: 10.1038/s41598-018-20654-0.
7
Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.
Oncol Lett. 2018 Mar;15(3):3273-3280. doi: 10.3892/ol.2017.7698. Epub 2017 Dec 27.
8
Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.
Dis Esophagus. 2014 May-Jun;27(4):355-9. doi: 10.1111/dote.12126. Epub 2013 Aug 29.
9
Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
Dis Esophagus. 2006;19(2):69-72. doi: 10.1111/j.1442-2050.2006.00542.x.
10
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma.
Radiother Oncol. 2015 Apr;115(1):9-15. doi: 10.1016/j.radonc.2015.03.019. Epub 2015 Mar 26.
本文引用的文献
1
Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma.
JAMA Otolaryngol Head Neck Surg. 2019 Nov 1;145(11):1012-1019. doi: 10.1001/jamaoto.2019.2427.
2
Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8 Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
Anticancer Res. 2019 Aug;39(8):4539-4548. doi: 10.21873/anticanres.13631.
3
Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):319-328. doi: 10.1016/j.ijrobp.2019.06.079. Epub 2019 Jun 19.
4
Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis.
Oncoimmunology. 2019 Apr 3;8(7):1593806. doi: 10.1080/2162402X.2019.1593806. eCollection 2019.
5
The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
World J Surg Oncol. 2019 May 22;17(1):85. doi: 10.1186/s12957-019-1621-9.
6
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma.
Mol Biol Rep. 2019 Jun;46(3):2713-2720. doi: 10.1007/s11033-019-04715-9. Epub 2019 Mar 6.
7
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1682-1693.e1. doi: 10.1016/j.jtcvs.2018.11.131. Epub 2018 Dec 15.
8
Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.
Ann Surg. 2020 Apr;271(4):693-700. doi: 10.1097/SLA.0000000000002985.
9
Low PD-1 Expression in Cytotoxic CD8 Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value.
Clin Cancer Res. 2018 Jan 15;24(2):407-419. doi: 10.1158/1078-0432.CCR-17-2156. Epub 2017 Oct 26.
10
Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.
J Thorac Oncol. 2016 Dec;11(12):2227-2237. doi: 10.1016/j.jtho.2016.07.031. Epub 2016 Aug 17.
Zotero 插件